Good old reliable milk. New research found that when it's combined with particular oral drugs, milk significantly improves ...

Drug developer GSK is vacating its 635,000-square-foot life sciences lab in Rockville, Maryland, where it was the sole tenant ...

These compounds take a different approach to weight loss than existing medications, which can cause nausea, vomiting and ...

However, they also found that GLP-1 drugs may lead to gastrointestinal, kidney, and pancreas issues. The researchers recommend that doctors closely monitor their patients as these medications ...

The role of the Gastrointestinal Drugs Advisory Committee (GIDAC) is to review and evaluate available data ‘concerning the safety and effectiveness of marketed and investigational human drug ...

Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of patients with extra-pancreatic ...

A recent commentary article published in Diabetes, Metabolic Syndrome and Obesity provides dietary recommendations for ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ways they affect the body—both helpful and harmful—beyond reducing weight.

Ltd (Stock Code: 02157.HK) for MRG007, an antibody-drug conjugate (ADC) that can target several gastrointestinal (GI) cancers. Under the terms of the agreement, ArriVent obtains the exclusive ...

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...

GI Innovation's next-generation immuno-oncology drug candidate GI-102 has been designated as a 'rare drug in development stage.' The company noted on the 16th that the Ministry of Food and Drug ...